Other
Bupivacaine
2
Pipeline Programs↗
11
Active Trials↗
3
Companies Involved↗
Bupivacaine is an early-stage landscape with 2 programs across 3 companies. The most active players are Heron Therapeutics, Grace Therapeutics Inc., AstraZeneca. 2 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Analysis
Trial Status
118
clinical trials
Completed75 · 64%
Unknown status16 · 14%
Withdrawn7 · 6%
Recruiting6 · 5%
Terminated6 · 5%
Not yet recruiting4 · 3%
Other4 · 3%
Clinical Trials
Trial Activity
118 trials
Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery
Recruiting·—·Phase 2·NCT07465185·300 enrolled
Local LevoBupivacaine for Pain Relief After Endoscopic Submucosal Dissection for Esophageal Lesions
Recruiting·—·N/A·NCT06611176·88 enrolled
Bupivacaine and Epinephrine Injection Study
Recruiting·—·Phase 2/3·NCT06456255·80 enrolled
Bupivacaine With Epinephrine Over Diaphragm in Laparoscopy
Not yet recruiting·—·Phase 4·NCT07400146·100 enrolled
Effect of Hyaluronidase in Different Doses Added to Bupivacaine on TAB Block Quality During CS
Not yet recruiting·—·Phase 1·NCT06839391·120 enrolled
Dexmeditomedine as an Adjuvant to Levobupivacaine in Transversus Thoracis Plane Block on the Management of Post-sternotomy Pain in Open-heart Surgeries
Not yet recruiting·—·N/A·NCT06410404·60 enrolled
Analgesic Effect of Bupivacaine Plus Ketamine Versus Bupivacaine Alone in Transversalis Fascia Plane Block
Not yet recruiting·—·Phase 1·NCT06935669·68 enrolled
Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth) Extraction
Completed·National Institute of Dental and Craniofacial Research (NIDCR)·Phase 2·NCT00050362·136 enrolled
Page 1 of 8
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)